From: Delays in childhood immunization in a conflict area: a study from Sierra Leone during civil war
Age group (months) | I (0 – 8) | II (9 – 11) | III (12 – 23) | IV (24 – 35) | Total |
---|---|---|---|---|---|
Number (%) | Number (%) | Number (%) | Number (%) | ||
Total in group | 46 (100) | 58 (100) | 83 (100) | 99 (100) | 286 (100) |
BCG | 39 (85) | 48 (83) | 73 (88) | 91 (92) | 251 (88) |
OPV-1 | 38 (83) | 49 (85) | 71 (86) | 85 (86) | 243 (85) |
OPV-2 | 34 (74) | 45 (78) | 64 (77) | 77 (78) | 220 (77) |
OPV-3 | 25 (54) | 37 (64) | 57 (69) | 71 (72) | 190 (66) |
DTP-1 | 38 (83) | 49 (84) | 70 (84) | 84 (85) | 241 (84) |
DTP-2 | 34 (74) | 45 (78) | 63 (76) | 76 (77) | 218 (76) |
DTP-3 | 25 (54) | 37 (64) | 58 (70) | 70 (71) | 190 (66) |
Measles | - | 16 (28) | 55 (66) | 68 (69) | 139 (58)* |
DTP Booster | - | - | 10 (12) | 8 (8) | 18 (10)** |
Measles Booster | - | - | 14 (17) | 11 (11) | 25 (14)** |